Membio's bioreactor technology acquired by ABEC

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Membio’s bioreactor technology has been acquired by ABEC, a leading global supplier of stainless steel and single-use integrated solutions and services for biopharmaceutical manufacturing. When brought to market, this technology will give customers a significant advantage in manufacturing their cellular products.

Membio is an alumnus of our BDSP™ and WiHI programs.

Read more
Arsheen Kaur
Previous

Nanostics receives funding from the University of Alberta Innovation Fund to propel adoption of the ClarityDX Prostate test
Next

KA Imaging's inCiTe 3D X-ray Microscope to support orthopaedic research at the University of Waterloo